![Drayton Wise](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Drayton Wise
Direttore/Membro del Consiglio presso
IRULYA THERAPEUTICS INC.
Profilo
Mr. Drayton Wise is on the Board of Directors at IRulya Therapeutics, Inc. Mr. Wise was previously employed as a Chief Commercial Officer by Insmed, Inc. He received his MBA from Emory University.
Posizioni attive di Drayton Wise
| Società | Posizione | Inizio |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Direttore/Membro del Consiglio | 08/10/2026 |
Precedenti posizioni note di Drayton Wise
| Società | Posizione | Fine |
|---|---|---|
| INSMED INCORPORATED | Corporate Officer/Principal | 16/04/2025 |
Formazione di Drayton Wise
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
40
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
